PACB
$1.33-0.07 (-5.00%)
Pacific Biosciences of California, Inc.
Recent News
Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know
In the closing of the recent trading day, Pacific Biosciences of California (PACB) stood at $1.33, denoting a -5% move from the preceding trading day.
3 Small-Cap Stocks with Warning Signs
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Pacific Biosciences (PACB) Upgraded to Strong Buy: What Does It Mean for the Stock?
Pacific Biosciences (PACB) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after easing crude oil prices helped lift investor sentiment and reduce inflation worries.
3 of Wall Street’s Favorite Stocks We Think Twice About
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.